Form D - Notice of Exempt Offering of Securities:
SEC Accession No. 0001744333-19-000001
Filing Date
2019-12-02
Accepted
2019-12-02 15:24:56
Documents
1
Effectiveness Date
2019-12-02
Items
Item 06b:

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D  
1 primary_doc.xml D 7223
  Complete submission text file 0001744333-19-000001.txt   8285
Mailing Address 855 N. WOLFE ST. SUITE 619 BALTIMORE MD 21205
Business Address 855 N. WOLFE ST. SUITE 619 BALTIMORE MD 21205 443-869-5420
ELIXIRGEN THERAPEUTICS, INC. (Filer) CIK: 0001744333 (see all company filings)

EIN.: 830534578 | State of Incorp.: DE | Fiscal Year End: 1231
Type: D | Act: 33 | File No.: 021-354561 | Film No.: 191263151